骨SPECT/CT在足踝关节融合术及邻近关节继发性骨关节炎评估中的价值
回顾性评估72例患者140个足踝关节融合术后SPECT/CT,融合成功率为62%~100%不等;融合率随术后时间延长从6~12个月的42%升至24个月以上的89%;131个邻近关节观察到骨关节炎,SPECT/CT对继发性骨关节炎评估价值更高,并提出「Lucerne标准」四型分类。
要点
- SPECT/CT评估足踝融合成功率为62%~100%,不同关节部位不等。
- 融合率6~12个月为42%,13~24个月为59%,24个月以上为89%。
- 11个再融合失败关节均为CT融合0级且放射性摄取2或3级。
核心结论
- 骨SPECT/CT是评估足踝关节融合术的有价值混合影像工具,对邻近关节继发性骨关节炎的评估价值更高。
- 作者提出结合代谢与形态学SPECT/CT信息的四型分类「Lucerne标准」用于评估融合关节。
研究设计与样本
- 回顾性评估72例患者足踝140个关节的SPECT/CT,包括34个上踝关节、28个下踝关节、27个距舟关节、12个跟骰关节和39个其他较小关节。
- CT融合分级:0=无融合,1=融合<50%,2=融合>50%,3=完全融合;SPECT放射性摄取分级:0=无摄取,1=轻度摄取,2=中度摄取,3=高度摄取。
- 骨关节炎严重程度分级:1=轻度,2=中度,3=重度;54例患者有随访干预的临床信息。
主要发现
- SPECT/CT判断融合成功(CT融合2或3级且摄取0或1级)比例:上踝关节73%(25/34)、下踝关节71%(20/28)、距舟关节67%(18/27)、跟骰关节100%(12/12)、其他较小关节62%(24/39)。
- 12个关节SPECT/CT表现不一致:融合2级且摄取2或3级9个,融合0或1级且摄取1级3个。
- 融合率术后6~12个月为42%(14/33),13~24个月为59%(20/34),24个月以上为89%(65/73)。
- 融合关节平均放射性摄取随术后时间下降:6~12个月1.60,12~24个月1.32,24个月以上0.38;放射性摄取分级与CT融合分级呈显著负相关。
- 随访期间33个关节接受额外融合术,其中11个再融合、22个为骨关节炎邻近关节的新融合;11个融合失败关节均为CT融合0级且摄取2或3级,22个后续融合的骨关节炎邻近关节均为摄取2或3级且原融合关节均愈合。
关键数值与推荐
- 融合成功定义为CT融合2或3级且放射性摄取0或1级。
- 骨关节炎在131个邻近关节中观察到。
- 作者提出「Lucerne标准」四型分类,结合代谢与形态学SPECT/CT信息评估融合关节。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the value of SPECT/CT (single photon emission computed tomography/computed tomography) in foot and ankle arthrodesis and development of secondary osteoarthritis in the adjacent joints. MATERIALS AND METHODS: SPECT/CT of 140 joints in the foot and ankle (34 upper ankle (UA), 28 lower ankle (LA), 27 talonavicular (TN), 12 calcaneo-cuboidal (CC), and 39 other smaller joints after arthrodesis in 72 patients were evaluated retrospectively regarding fusion grade in CT (0 = no fusion, 1 = < 50% fusion, 2 = > 50% fusion, 3 = complete fusion) and radiotracer uptake (0 = no uptake, 1 = mild uptake, 2 = moderate uptake, 3 = high uptake) on SPECT/CT. Severity of osteoarthritis (1 = mild, 2 = moderate, 3 = severe) and radiotracer uptake grade in adjacent joints was also assessed. In 54 patients, clinical information about interventions in the follow-up was available. RESULTS: According to the SPECT/CT, arthrodesis was successful (grade 2 or 3 CT fusion and grade 0 or 1 uptake) in 73% (25/34) of UA joints, 71% (20/28) of LA joints, 67% (18/27) TN, 100% (12/12) CC joints, and 62% (24/39) of other smaller joints. In 12 joints, there were discrepant findings in SPECT/CT (fusion grade 2 and uptake grade 2 or 3 (n = 9); or, fusion grade 0 or 1 and uptake grade 1 (n = 3)). The fusion rate 6-12 months after arthrodesis was 42% (14/33), 59% (20/34) after 13-24 months, and 89% (65/73) after more than 24 months, respectively. Average radiotracer uptake in arthrodesis decreased with age: 6-12 months: 1.60, 12-24 months: 1.32, > 24 months: 0.38. There was a significant negative correlation between radiotracer uptake grade and CT fusion grade. Osteoarthritis was observed in 131 adjacent joints. During the post scan follow-up, additional arthrodeses were performed in 33 joints, of which 11 joints were re-arthrodesis and 22 were new arthrodeses in osteoarthritic adjacent joints. All these 11 joints with failed arthrodesis had grade 0 of CT fusion and grade 2 or 3 of radiotracer uptake. All 22 adjacent joints with osteoarthritis, which subsequently underwent arthrodesis, had grade 2 or 3 radiotracer uptake, and the primary arthrodesis joints were healed and fused in all these cases. CONCLUSION: Bone SPECT/CT is a valuable hybrid imaging tool in the evaluation of foot and ankle arthrodesis and gives additional useful information about the development of secondary osteoarthritis in the adjacent joints with higher value for the assessment of secondary osteoarthritis. A practical four-type classification ('Lucerne Criteria') combining metabolic and morphologic SPECT/CT information for evaluation of arthrodesis joints has been proposed.
引用
- Bhure U, Grünig H, Del Sol Pérez Lago M, et al. The value of bone SPECT/CT in evaluation of foot and ankle arthrodesis and adjacent joint secondary osteoarthritis. Eur J Nucl Med Mol Imaging. 2023. PMID: 37676502. doi:10.1007/s00259-023-06421-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。